| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $282.84B | +9.8% |
| Cost of Revenue | $126.20B | +13.8% |
| R&D Expense | $39.50B | +25.2% |
| SG&A Expense | $15.72B | +16.4% |
| Operating Income | $74.84B | -4.9% |
| Interest Expense | $357.0M | +3.2% |
| Pre-tax Income | $71.33B | -21.4% |
| Income Tax | $11.36B | -22.8% |
| Net Income | $59.97B |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.88B | +4.5% |
| Short-term Investments | $91.88B | -22.6% |
| Accounts Receivable | $40.26B | +2.4% |
| Inventory | $2.67B | +128.2% |
| Current Assets | $164.79B | -12.4% |
| Total Assets | $365.26B | +1.7% |
| Current Liabilities | $69.30B | +7.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $91.50B | -0.2% |
| Capital Expenditures | $31.48B | +27.8% |
| Investing Cash Flow | -$20.30B | +42.9% |
| Financing Cash Flow | -$69.76B | -13.7% |
| Free Cash Flow | $60.01B | -10.4% |
| -21.1% |
| EPS (Basic) | $4.59 | -96.0% |
| EPS (Diluted) | $4.56 | -95.9% |
| Long-term Debt |
| $15.31B |
| -0.8% |
| Total Liabilities | $109.12B | +1.4% |
| Stockholders' Equity | $256.14B | +1.8% |